KLF2 interacts with AP-1 to negatively affect osteoclast differentiation and activity

Area of Science:

• Bone Biology
• Cellular and Molecular Biology
• Immunology

Background:

• Osteoclasts are crucial for bone resorption and homeostasis.
• Krüppel-like factor 2 (KLF2) is linked to osteoclast differentiation, but its mechanism is unclear.

Purpose of the Study:

• Investigate KLF2's role in osteoclastogenesis, maturation, and activity.
• Elucidate the biomechanisms underlying KLF2's regulation of osteoclasts.

Main Methods:

• Characterization of osteoclast number, size, and markers.
• Assessment of actin ring and podosome cluster formation.
• Analysis of intracellular acidification via KLF2 overexpression and knockdown.
• Chromatin immunoprecipitation (ChIP) and co-immunoprecipitation (Co-IP) assays.
• Investigation of the RANKL-MAPK-AP-1-NFATc1 signaling axis.

Main Results:

• KLF2 negatively regulates osteoclastogenesis, maturation, and activity.
• KLF2 directly interacts with c-Fos and c-Jun, components of the activator protein-1 (AP-1) complex.
• KLF2 mediates osteoclast function through negative regulation of the AP-1 complex.
• JNK signaling inhibition reduces AP-1 activation in KLF2 knockdown cells, highlighting the RANKL-MAPK-AP-1-NFATc1 pathway.

Conclusions:

• KLF2 acts as a negative regulator of osteoclast function.
• KLF2's mechanism involves the negative regulation of the AP-1 complex via the RANKL-MAPK-AP-1-NFATc1 axis.
• KLF2 represents a potential therapeutic target for osteolytic diseases such as osteoporosis.